Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies (North American Mitochondrial Disease Consortium, Rare Diseases Clinical Research Network, Project 7413)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Children and adults with pyruvate dehydrogenase complex deficiency (PDCD) are participating in a research study seeking to better understand the genetic causes, symptoms, usefulness of current treatments, and outcomes for these disorders. The research project involves completing a questionnaire about the individual or family's medical history and experiences with PDCD, review of medical records by the researchers, and in some cases, advanced genetic testing.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Low PDC activity in skin fibroblasts, blood lymphocytes or a muscle biopsy, below the reference range, and with valid internal controls to establish sample and assay integrity, and have had PDHA1 testing, and/or

• A known pathogenic mutation of a gene associated with PDC deficiency.

⁃ Relative Subjects Inclusion Criteria:

⁃ 1\. First or second degree relative of a primary subject for whom genetic testing indicates the presence of variants of unknown significance (VUS).

Locations
United States
Pennsylvania
University of Pittsburgh
RECRUITING
Pittsburgh
Contact Information
Primary
Danielle Black, MPH
danielle.black@chp.edu
412-692-6893
Backup
Jirair K. Bedoyan, MD, PhD
bedoyanjk@upmc.edu
412-692-6893
Time Frame
Start Date: 2015-09
Estimated Completion Date: 2026-09
Participants
Target number of participants: 150
Treatments
PDC Deficiency
Pyruvate Dehydrogenase Complex Deficiency Disease
Sponsors
Leads: University of Pittsburgh
Collaborators: Rare Diseases Clinical Research Network, National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov